In my previous post on this subject, I wrote of how new products in prenatal testing have caused several false testing reports, causing many expectant couples to elect abortions, out of fear that the fetus would be born with severe birth defects.
The tests, which can be conducted as early as nine weeks of pregnancy, detect placental DNA in the mother’s blood and test it for chromosomal abnormalities, as well as gender. The tests were originally designed for older women and women at high risk of pregnancy difficulties, but many of these tests are now marketed to all pregnant women. Industry analysts estimate that between 450,000 to 800,000 of these tests have been performed in the United States since 2011. Several companies are racing to corner what some analysts predict could be a $3.6 billion global industry by the year 2019. Continue reading